00:36 , Oct 19, 2018 |  BC Innovations  |  Tools & Techniques

Allogeneic CARs on the horizon

With the first generation of autologous, personalized CAR T cell therapies on the market, the field is turning to allogeneic technologies to provide better scale and lower costs. But drug makers are learning that as...
13:36 , Sep 14, 2017 |  BC Innovations  |  Translation in Brief

New Therapeutic Targets and Biomarkers: August 2017

New Therapeutic Targets and Biomarkers: August 2017...
19:27 , Sep 11, 2017 |  BC Innovations  |  Distillery Techniques

Drug delivery

TECHNOLOGY: Nanoparticles Poly(amine-co-ester) nanoparticles could be used to deliver therapeutic nucleic acids to prevent transplant rejection. The method involves pre-transplant,...
08:00 , Dec 8, 2008 |  BC Week In Review  |  Company News

University of Maryland Baltimore County other research news

University researchers published in the Proceedings of the National Academy of Sciences the ability of tumor cells transfected with major histocompatibility complex (MHC) class II genes to present endogenous antigen and induce tumor-specific immunity. Expression...
08:00 , Mar 27, 2000 |  BC Week In Review  |  Company News

Antigen Express Inc. other research news

Antigen Express received a $173,000 Phase I SBIR grant from the National Cancer Institute to develop a colon cancer vaccine using cancer cells transfected with the MHC Class II transactivator gene (CIITA) and an antisense...